The analyst's Medical Devices sector report, “Aortic and Vascular Graft Devices Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update" provides comprehensive information about the Aortic and Vascular Graft Devices pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.
Aortic Stent grafts are used to reinforce a weaken aorta to prevent ruptures. Vascular grafts are tubes made up of natural tissue or synthetic materials surgically implanted in the veins and arteries.
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.
Aortic Stent grafts are used to reinforce a weaken aorta to prevent ruptures. Vascular grafts are tubes made up of natural tissue or synthetic materials surgically implanted in the veins and arteries.
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.
Scope
- Extensive coverage of the Aortic and Vascular Graft Devices under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Aortic and Vascular Graft Devices and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry
Reasons to Buy
The report enables you to :
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
- Identify and understand important and diverse types of Aortic and Vascular Graft Devices under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product’s current stage of development, territory and estimated launch date
Table of Contents
1 Table of Contents
2 Introduction
3 Products under Development
4 Aortic and Vascular Graft Devices - Pipeline Products under Development by Companies
5 Aortic and Vascular Graft Devices Companies and Product Overview
6 Aortic and Vascular Graft Devices- Recent Developments
7 Appendix
List of Tables
List of Figures
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Acro Biomedical Co Ltd
- BioLife4D Corp
- Cook Medical Inc
- Drexel University
- Endomimetics LLC
- Endoron Medical Ltd
- Humacyte Inc
- Innoventric Ltd
- Merit Medical Systems Inc
- Shanghai MicroPort Endovascular MedTech Group Co Ltd
- Stanford University
- Strait Access Technologies (Pty) Ltd
- University of Toledo
- Vascular Graft Solutions Ltd
- Verigraft AB
